Answer
Eliglustat tartrate inhibits glucosylceramide synthase, reducing glucosylceramide production to match its impaired breakdown in Gaucher disease type 1, thereby preventing its accumulation and alleviating clinical manifestations.
Sources for this answer
- Cerdelga 84 mg capsules, hardSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 11Document updated
Sources checked